Company intelligence / Profile preview

Qunomedical

Ownership: Private
Employees: ~60
Development stage: Commercial

Overview

Qunomedical operates an active digital health platform connecting patients with vetted doctors and clinics globally. It also offers the "Qunosuite" SaaS for healthcare providers to manage patient relationships. The company serves over 6,500–10,000 patients monthly across six European countries with more than 35 clinics and 1,000+ physicians in its network. Qunomedical is a Berlin-based company founded by Dr. Sophie Chung that does not develop drugs or therapies but instead focuses on improving transparency and quality within global healthcare delivery through technology-enabled solutions.

Therapeutic areas: Men's HealthOncologyMetabolic DisordersOtherCardiovascularOphthalmologyWomen's Health
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Qunomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qunomedical.

Explore the full profile